Immunotech Biopharm Statistics

Total Valuation

HKG:6978 has a market cap or net worth of HKD 1.54 billion. The enterprise value is 1.89 billion.

Market Cap	1.54B
Enterprise Value	1.89B

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:6978 has 514.58 million shares outstanding.

Current Share Class	514.58M
Shares Outstanding	514.58M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.03%
Owned by Institutions (%)	0.06%
Float	37.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-88.17
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.49
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.60

Financial Position

The company has a current ratio of 0.20

Current Ratio	0.20
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.51
Interest Coverage	-26.81

Financial Efficiency

Return on equity (ROE) is -242.61% and return on invested capital (ROIC) is -25.21%.

Return on Equity (ROE)	-242.61%
Return on Assets (ROA)	-17.81%
Return on Invested Capital (ROIC)	-25.21%
Return on Capital Employed (ROCE)	-150.11%
Revenue Per Employee	n/a
Profits Per Employee	-1.29M
Employee Count	154
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:6978 has paid 985,424 in taxes.

Income Tax	985,424
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.47% in the last 52 weeks. The beta is 0.86, so HKG:6978's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	-4.47%
50-Day Moving Average	3.50
200-Day Moving Average	2.97
Relative Strength Index (RSI)	39.43
Average Volume (20 Days)	437,800

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-213.79M
Pretax Income	-198.38M
Net Income	-198.91M
EBITDA	-150.69M
EBIT	-213.79M
Earnings Per Share (EPS)	-0.39

Full Income Statement

Balance Sheet

The company has 61.18 million in cash and 409.24 million in debt, giving a net cash position of -348.05 million or -0.68 per share.

Cash & Cash Equivalents	61.18M
Total Debt	409.24M
Net Cash	-348.05M
Net Cash Per Share	-0.68
Equity (Book Value)	-17.51M
Book Value Per Share	-0.03
Working Capital	-364.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -133.81 million and capital expenditures -29.01 million, giving a free cash flow of -162.82 million.

Operating Cash Flow	-133.81M
Capital Expenditures	-29.01M
Free Cash Flow	-162.82M
FCF Per Share	-0.32

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:6978 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.88%
FCF Yield	-10.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1